Know when retatrutide is approved.
Free email updates on trial results, FDA status and how to join a trial.
Independent educational digest. No dosing guidance, no marketing, no spam.
What's true today
Not approved
Not FDA-approved yet
Retatrutide is an investigational drug from Eli Lilly and is not approved by the FDA for any use.
In progress
Phase 3 trials ongoing
Late-stage trials are currently running at sites around the world.
Restricted
Only legal access is a trial
Retatrutide cannot be prescribed or legally bought today. Joining a trial is the only lawful route.
How to join a trial
Trials list where they are recruiting. Here is how to find one.
- 01
Search for open trials
Look up retatrutide on ClinicalTrials.gov to see which sites are recruiting near you.
Search ClinicalTrials.gov - 02
Check the eligibility rules
Each trial lists who can join, including age, BMI and health history.
- 03
Contact the study team
Use the contact details on the trial page to ask about screening.
Status timeline
- Early researchCompleted
- Early safety trialsCompleted
- Dose-finding trialsCompleted
- Phase 3 trialsIn progress
- FDA submissionUpcoming
- FDA decisionUpcoming